ZEGA Investments LLC purchased a new stake in shares of The Allstate Co. (NYSE:ALL – Free Report) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 1,124 shares of the insurance provider’s stock, valued at approximately $209,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of ALL. Apella Capital LLC grew its stake in shares of Allstate by 1.9% during the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock valued at $623,000 after acquiring an additional 60 shares during the period. Avior Wealth Management LLC boosted its position in shares of Allstate by 4.9% in the third quarter. Avior Wealth Management LLC now owns 1,329 shares of the insurance provider’s stock worth $252,000 after purchasing an additional 62 shares during the period. Perigon Wealth Management LLC boosted its position in shares of Allstate by 2.1% in the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider’s stock worth $571,000 after purchasing an additional 62 shares during the period. Mather Group LLC. boosted its position in shares of Allstate by 1.7% in the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider’s stock worth $697,000 after purchasing an additional 62 shares during the period. Finally, Angeles Wealth Management LLC boosted its position in shares of Allstate by 4.6% in the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider’s stock worth $270,000 after purchasing an additional 62 shares during the period. Hedge funds and other institutional investors own 76.47% of the company’s stock.
Insider Buying and Selling
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares of the company’s stock, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 1.80% of the stock is owned by company insiders.
Allstate Stock Down 1.7 %
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating analysts’ consensus estimates of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. As a group, research analysts expect that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.
Allstate declared that its board has initiated a share repurchase program on Wednesday, February 26th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the insurance provider to purchase up to 3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.
Allstate Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Investors of record on Monday, March 10th will be paid a $1.00 dividend. The ex-dividend date of this dividend is Monday, March 10th. This is a boost from Allstate’s previous quarterly dividend of $0.92. This represents a $4.00 dividend on an annualized basis and a yield of 1.94%. Allstate’s dividend payout ratio (DPR) is 23.54%.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on ALL shares. Wells Fargo & Company upped their price target on shares of Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research report on Tuesday, January 14th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a research report on Wednesday, January 8th. Barclays dropped their price target on shares of Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research report on Monday, January 6th. Keefe, Bruyette & Woods upped their price target on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 11th. Finally, Argus upgraded shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Allstate presently has an average rating of “Moderate Buy” and an average price target of $217.94.
Get Our Latest Research Report on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- What is the MACD Indicator and How to Use it in Your Trading
- FedEx Delivers Another Crushing Blow to Its Stock Price
- 3 Warren Buffett Stocks to Buy Now
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- How is Compound Interest Calculated?
- Micron Stock Will Retest All-Time Highs This Year
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.